Volume 8 Issue 3
May  2017
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2017  >  8(3): 190-194, 231
Gu Shijie, Chen Yunhao, Zhao Hui,, et al. Effect of different transplantation approaches of human umbilical cord menchymal stem cells on repairing hepatic ischemia-reperfusion injury in rat models[J]. ORGAN TRANSPLANTATION, 2017, 8(3): 190-194, 231. doi: 10.3969/j.issn.1674-7445.2017.03.003
Citation: Gu Shijie, Chen Yunhao, Zhao Hui,, et al. Effect of different transplantation approaches of human umbilical cord menchymal stem cells on repairing hepatic ischemia-reperfusion injury in rat models[J]. ORGAN TRANSPLANTATION, 2017, 8(3): 190-194, 231. doi: 10.3969/j.issn.1674-7445.2017.03.003
shu

Effect of different transplantation approaches of human umbilical cord menchymal stem cells on repairing hepatic ischemia-reperfusion injury in rat models

doi: 10.3969/j.issn.1674-7445.2017.03.003

  • Department of Hepatic Surgery, Organ Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University, Transplantation Research Institute of Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Key Laboratory of Liver Disease Research of Guangdong Province, Guangzhou 510630, China

More Information
  • Corresponding author: Yi Shuhong, Email: yishuhong@163.com
  • Received Date: 2017-02-21
    Available Online: 2021-01-19
  • Publish Date: 2017-05-15
    Abstract
  •   Objective   To investigate the effect of different transplantation approaches of human umbilical cord menchymal stem cells (HU-MSCs) on repairing hepatic ischemia-reperfusion injury (HIRI) in rat models.   Methods   Forty male SD rats were randomly divided into the A (control group), B (model group), C (portal vein transplantation of MSCs group) and D (tail vein transplantation of MSCs group) groups (n=10 for each group). In the B, C and D groups, HIRI rat models were established by Pringle maneuver. MSC transplantation was not delivered in the B group, and chloromethyl-benzamidodialkylcarbocyanine (CM-DiL) labeled-HU-MSCs (106) were transplanted via portal vein or tail vein in the C or D groups. Blood samples were collected for detection of the expression levels of alanine aminotransferase(ALT) and tumor necrosis factor (TNF)-α before and 1, 3 and 5 d after transplantation. At 5 d post-transplantation, all rats in each group were sacrificed. The liver tissues were prepared for hematoxylin-eosin (HE) and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling(TUNEL) staining for evaluation of liver injury. The distribution of HU-MSCs in the rat liver in each group was observed under laser confocal microscope.   Results   After HU-MSCs transplantation, the expression levels of ALT in the C and D groups were significantly down-regulated compared with that in the B group, and the level of ALT in the C group was significantly lower than that in the D group (all P < 0.05). The expression levels of inflammatory cytokine TNF-α in the C and D groups were significantly lower than that in the B group and the TNF-α level in the C group was considerably lower than that in the D group (all P < 0.05). HE staining of the liver tissue prompted that the liver injury was the most severe in the B group, and the liver injury in the C group was less severe compared with that in the D group. TUNEL staining of the liver tissue revealed that the apoptosis index (AI) in the C and D groups was significantly lower than that in the B group, and the AI in the C group was significantly lower compared with that in the D group (all P < 0.05). Under laser confocal microscope, CM-DiL-labeled HU-MSCs were noted in the C and D groups after transplantation, and the quantity of HU-MSCs in the C group was significantly higher than that in the D group (all P < 0.05).   Conclusion   Transplantation of HU-MSCs can mitigate the severity of HIRI. And transplantation via portal vein transplantation yields higher clinical efficacy compared with the tail vein route.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    Nagamura-Inoue T, He H. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility[J]. World J Stem Cells, 2014, 6(2):195-202. DOI: 10.4252/wjsc.v6.i2.195.
    [2]
    Castro-Manrreza ME, Montesinos JJ. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications[J]. J Immunol Res, 2015:394917. DOI: 10.1155/2015/394917.
    [3]
    Papadopoulos D, Siempis T, Theodorakou E, et al. Hepatic ischemia and reperfusion injury and trauma: current concepts[J]. Arch Trauma Res, 2013, 2(2):63-70. DOI: 10.5812/atr.12501.
    [4]
    Jin G, Qiu G, Wu D, et al. Allogeneic bone marrow-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats[J]. Int J Mol Med, 2013, 31(6):1395-1401. DOI: 10.3892/ijmm.2013.1340.
    [5]
    Oguz A, Kapan M, Onder A, et al. The effects of curcumin on the liver and remote organs after hepatic ischemia reperfusion injury formed with Pringle manoeuvre in rats[J]. Eur Rev Med Pharmacol Sci, 2013, 17(4):457-466. https://www.researchgate.net/publication/235882025_The_effects_of_curcumin_on_the_liver_and_remote_organs_after_hepatic_ischemia_reperfusion_injury_formed_with_Pringle_manoeuvre_in_rats
    [6]
    Yang M, Antoine DJ, Weemhoff JL, et al. Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice[J]. Liver Transpl, 2014, 20(11):1372-1382. DOI: 10.1002/lt.23958.
    [7]
    Zhou HX, Liu ZG, Liu XJ, et al. Umbilical cord-derived mesenchymal stem cell transplantation combined with hyperbaric oxygen treatment for repair of traumatic brain injury[J]. Neural Regen Res, 2016, 11(1):107-113. DOI: 10.4103/1673-5374.175054.
    [8]
    Tsagias N, Kouzi-Koliakos K, Karagiannis V, et al. Pluripotent stem cells isolated from umbilical cord form embryonic like bodies in a mesenchymal layer culture[J]. Histol Histopathol, 2015, 30(3):373-382. DOI: 10.14670/HH-30.373.
    [9]
    Arutyunyan I, Elchaninov A, Makarov A, et al. Umbilical cord as prospective source for mesenchymal stem cell-based therapy[J]. Stem Cells Int, 2016:6901286. DOI: 10.1155/2016/6901286.
    [10]
    Yang S, Huang S, Feng C, et al. Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration[J]. Front Med, 2012, 6(1):41-47. DOI: 10.1007/s11684-012-0175-9.
    [11]
    Lynch K, Pei M. Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies[J]. Organogenesis, 2014, 10(3):289-298. DOI: 10.4161/15476278.2014.970089.
    [12]
    Ding DC, Chang YH, Shyu WC, et al. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy[J]. Cell Transplant, 2015, 24(3):339-347. DOI: 10.3727/096368915X686841.
    [13]
    Xiao B, Rao F, Guo ZY, et al. Extracellular matrix from human umbilical cord-derived mesenchymal stem cells as a scaffold for peripheral nerve regeneration[J]. Neural Regen Res, 2016, 11(7):1172-1179. DOI: 10.4103/1673-5374.187061.
    [14]
    Ji F, Duan HG, Zheng CQ, et al. Comparison of chloromethyl-dialkylcarbocyanine and green fluorescent protein for labeling human umbilical mesenchymal stem cells[J]. Biotechnol Lett, 2015, 37(2):437-447. DOI: 10.1007/s10529-014-1692-1.
    [15]
    杨小丽, 宋京翔, 高琴, 等.间充质干细胞对结肠癌细胞Hct-116形成的裸鼠肿瘤的影响[J/CD].中华细胞与干细胞杂志(电子版), 2015, 5(2):48-52. DOI: 10.3877/cma.j.issn.2095-1221.2014.04.010.

    Yang XL, Song JX, Gao Q, et al. Effect of mesenchymal stem cells on Hct-116 tumor development in nude mice[J/CD]. Chin J Cell Stem Cell(Electr Edit), 2015, 5(2):48-52. DOI:10.3877/cma.j.issn. 2095-1221. 2014. 04. 010.
    [16]
    武京国, 谢方南, 马慧雨, 等. EGFP和CM-Dil示踪骨髓间充质干细胞构建组织工程骨的体内研究[J].中国美容医学, 2012, 21(3):406-409. DOI: 10.3969/j.issn.1008-6455.2012.03.026.

    Wu JG, Xie FN, Ma HY, et al. The in vivo study of tissue engineered bone constructed with EGFP and CM-Dil labeled BMSCs[J]. Chin J Aesth Med, 2012, 21(3):406-409.DOI: 10.3969/j.issn.1008-6455.2012.03.026.
    [17]
    Nastos C, Kalimeris K, Papoutsidakis N, et al. Global consequences of liver ischemia/reperfusion injury[J]. Oxid Med Cell Longev, 2014:906965. DOI: 10.1155/2014/906965.
    [18]
    Saidi RF, Kenari SK. Liver ischemia/reperfusion injury: an overview[J]. J Invest Surg, 2014, 27(6):366-379. DOI: 10.3109/08941939.2014.932473.
    [19]
    Isbambetov A, Baimakhanov Z, Soyama A, et al. Equal distribution of mesenchymal stem cells after hepatic ischemia-reperfusion injury[J]. J Surg Res, 2016, 203(2):360-367. DOI: 10.1016/j.jss.2016.03.057.
    [20]
    Kanazawa H, Fujimoto Y, Teratani T, et al. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model[J]. PLoS One, 2011, 6(4):e19195. DOI: 10.1371/journal.pone.0019195.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (110) PDF downloads(8) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return